Novartis readies for FDA review of $1 billion CAR-T child cancer hope

ZURICH (Reuters) - Two decades ago in a Memphis, Tenn., hospital lab, cancer scientist Dario Campana and his team were hunting for a new way to fight deadly acute lymphoblastic leukemia (ALL).